Events

Webinar “Maximizing the Impact of Horizon 2020 project results”
JUL
Wed
07
10:30 - 12:00

This was 4 years ago

Location

virtual

Programmes
Horizon 2020 H2020 L+F

The European Innovation Council and Small and Medium-sized Enterprises Executive Agency (EISMEA) in collaboration with the European IP Helpdesk organise a webinar on exploitation of IP rights in H2020 projects. “After the training, participants should have a better understanding of the following:

  • The IP in the Consortium Agreements: a particular regard to the results of the research.
  • Which are the best means to maximize the value of your IP?
  • Assessing your IP: How can you estimate the value of your IP?
  • Which are the best exploitation strategies and business plans for entering the market?
  • Reap the rewards of your IP: taking a closer look at the different forms of licensing.”

All info, agenda and registration form can be found on the webpage of the European IP Helpdesk

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.